Monensin inhibits the growth of renal cell carcinoma cells via cell cycle arrest or apoptosis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Oncology

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.22.4.855PMID 12632079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis.

  2003cited by this paper
• Monensin‐mediated growth inhibition in acute myelogenous leukemia cells via cell cycle arrest and apoptosis

  2002cited by this paper
• The machinery of programmed cell death.

  2001cited by this paper
• To cycle or not to cycle: a critical decision in cancer

  2001cited by this paper
• Attenuation of apoptotic DNA fragmentation by amiloride

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Regulation of transcription by proteins that control the cell cycle

  1997cited by this paper
• Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.

  1997cited by this paper
• Caspases: the executioners of apoptosis.

  1997cited by this paper
• Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked

  1997cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Radiation-induced cell cycle arrest compromised by p21 deficiency

  1995cited by this paper
• Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex

  1995cited by this paper
• Effects of Na+/H+ antiport and intracellular pH in the regulation of HL-60 cell apoptosis.

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Cdk inhibitors: on the threshold of checkpoints and development.

  1994cited by this paper
• 19F-NMR study of primary human T lymphocyte activation: effects of mitogen on intracellular pH.

  1994cited by this paper
• Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle.

  1994cited by this paper
• Apoptosis in cancer therapy: crossing the threshold.

  1994cited by this paper
• Monensin-mediated antiport of Na+ and H+ across liposome membrane.

  1991cited by this paper
• Na+/H+ antiporter gene expression during monocytic differentiation of HL60 cells.

  1991cited by this paper
• Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity

  1990cited by this paper
• Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation.

  1989cited by this paper
• Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells.

  1988cited by this paper
• Biological applications of ionophores.

  1976cited by this paper

• Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models.

  2025cites this paper
• Endosomal recycling inhibitors downregulate estrogen receptor-alpha and synergise with endocrine therapies

  2024cites this paper
• Endosomal recycling inhibitors downregulate the androgen receptor and synergise with enzalutamide

  2023cites this paper
• Investigation of the anticancer mechanism of monensin via apoptosis‐related factors in SH‐SY5Y neuroblastoma cells

  2023cites this paper
• Effect of antibiotic monensin on cell proliferation and IGF1R signaling pathway in human colorectal cancer cells

  2023cites this paper
• Guanine nucleotide-binding protein 2, GNBP2, accelerates the progression of clear cell renal cell carcinoma via regulation of STAT3 signaling transduction pathway

  2022cites this paper
• Maduramicin arrests myocardial cells at G0/G1 phase of the cell cycle through inhibiting AKT-Cyclin D1 signaling

  2021cites this paper
• High content screening identifies monensin as an EMT-selective cytotoxic compound

  2019cites this paper
• Spectral properties and biological activity of La(III) and Nd(III) Monensinates

  2019cites this paper
• Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs.

  2019cites this paper
• Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway

  2018cites this paper
• Quantitative determination of the veterinary drug monensin in horse feed samples by square wave voltammetry (SWV) and direct infusion electrospray ionization tandem mass spectrometry (DI–ESI–MS/MS)

  2018cites this paper
• Maduramicin induces apoptosis in chicken myocardial cells via intrinsic and extrinsic pathways.

  2018cites this paper
• Monensin induces cell death by autophagy and inhibits matrix metalloproteinase 7 (MMP7) in UOK146 renal cell carcinoma cell line

  2018cites this paper
• Changes In Threonyl-Trna Synthetase Expression And Secretion In Response To Endoplasmic Reticulum Stress By Monensin In Ovarian Cancer Cells

  2017cites this paper
• Monensin, a small molecule ionophore, can be used to increase high mannose levels on monoclonal antibodies generated by Chinese hamster ovary production cell‐lines

  2015cites this paper
• Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells

  2015cites this paper
• Testicular effects of monensin, a golgi interfering agent in male rats

  2014cites this paper
• Small Molecule Therapeutics Monensin Inhibits Epidermal Growth Factor Receptor Traf fi cking and Activation : Synergistic Cytotoxicity in Combination with EGFR Inhibitors

  2014cites this paper
• Maduramicin Inhibits Proliferation and Induces Apoptosis in Myoblast Cells

  2014cites this paper
• Monensin Inhibits Canonical Wnt Signaling in Human Colorectal Cancer Cells and Suppresses Tumor Growth in Multiple Intestinal Neoplasia Mice

  2014cites this paper
• Monensin Inhibits Epidermal Growth Factor Receptor Trafficking and Activation: Synergistic Cytotoxicity in Combination with EGFR Inhibitors

  2014cites this paper
• Gramicidin A Induces Metabolic Dysfunction and Energy Depletion Leading to Cell Death in Renal Cell Carcinoma Cells

  2013cites this paper
• In Vitro Activity of Biometal(II) Complexes of Monensin Against Virus-Induced Transplantable Animal Tumors

  2013cites this paper
• Structure and Antimicrobial Properties of Monensin A and Its Derivatives: Summary of the Achievements

  2013cites this paper
• Crown Ether Host-Rotaxanes as Cytotoxic Agents.

  2013cites this paper
• Novel Combination Therapy: Monensin Potentiates Erlotinib-Induced Cytotoxicity.

  2013cites this paper
• Small Molecule Therapeutics Gramicidin A Induces Metabolic Dysfunction and Energy DepletionLeading toCellDeath inRenalCellCarcinomaCells

  2013cites this paper
• Journal of Experimental and Clinical Medicine Deneysel ve Klinik Tip Dergisi

  2012cites this paper
• ETS-dependent p16INK4a and p21waf1/cip1 gene expression upon endothelin-1 stimulation in malignant versus and non-malignant proximal tubule cells.

  2012cites this paper
• Chemical Biology Screen for Prostate Cancer Therapeutics

  2011cites this paper
• Antitumor activity of the polyether ionophorous antibiotic Monensin and its metal ( II ) complexes

  2011cites this paper
• Cytotoxic and antiproliferative activities of monensic acid and its metal(II) complexes against drug sensitive and multidrug resistant human tumor cell lines

  2011cites this paper
• Expression profile of apoptosis related genes and radio-sensitivity of prostate cancer cells.

  2011cites this paper
• Monensin Is a Potent Inducer of Oxidative Stress and Inhibitor of Androgen Signaling Leading to Apoptosis in Prostate Cancer Cells

  2010cites this paper
• Therapeutic Discovery Monensin Is a Potent Inducer of Oxidative Stress and Inhibitor of Androgen Signaling Leading to Apoptosis in Prostate Cancer Cells

  2010cites this paper
• High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

  2009cites this paper
• Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis.

  2009cites this paper
• Cancer Therapy: Preclinical High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

  2009cites this paper
• BIOLOGICZNE WŁAŚCIWOŚCI MONENZYNY A

  2008cites this paper
• Effect of monensin, a Na+-specific carboxylic ionophore on the oxidative defense system in rat testis.

  2007cites this paper
• Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients

  2006cites this paper
• Changes in endosome-lysosome pH accompanying pre-malignant transformation.

  2005cites this paper
• Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.

  2005cites this paper